Current Affairs Coronavirus Thread - Serious stuff !!!

Status
Not open for further replies.
Aye concerns exist about the number of older people tested in phase 1 and 2. Phase 3 results are now being made available and they show that it was given to some 1400 people aged 55 and over in Brazil and U.K. and the results show a strong immune response in that age group with 70-90% efficacy.

This particular vaccine will help so many people across the world. Of all of them I’d say this one is the most important.
1,400 out of 24,000 participants.

A third of the UK population is over 55 years old.

Does that look like it's a reliable number of participants?
 
Oh ffs, how bloody hard is it for the people leading this to model good behaviour :rant:
WASHINGTON (AP) — As COVID-19 cases skyrocketed before the Thanksgiving holiday weekend, Dr. Deborah Birx, coordinator of the White House coronavirus response, warned Americans to “be vigilant” and limit celebrations to “your immediate household.”

For many Americans that guidance has been difficult to abide, including for Birx herself.

The day after Thanksgiving, she traveled to one of her vacation properties on Fenwick Island in Delaware. She was accompanied by three generations of her family from two households. Birx, her husband Paige Reffe, a daughter, son-in-law and two young grandchildren were present.
Clearly, not the main point of the article, but she has multiple vacation houses and a massive house in Potomac (most expensive area in Maryland).
I never realized Dr. Birx was such a baller
 
1,400 out of 24,000 participants.

A third of the UK population is over 55 years old.

Does that look like it's a reliable number of participants?
It was actually 1440 out of 11000 in phase 3 trials. I don’t have the numbers for phase 1 and 2.

Overall more data is needed on the over 55’s and that’s why trials are continuing focused on the over 55’s. The results are expected within the next 10 days.

Also note that due to the severe allergic reactions seen with the Pfizer vaccine every person who gets the dose now has to be monitored for 15 minutes following the vaccine.

this has prompted a number of Gp surgery’s to remove themselves from the program as they don’t have the staff to support this. This will only serve to delay the rollout of this particular vaccine.
No such problems seen with the Oxford vaccine.

I think all of us have to bear in mind that development time of all the vaccines was compressed from 3 years to 9 months. That in itself is an unbelievable achievement.

If you’re still not happy to receive the Oxford Vaccine, you could always opt for the Sputnik V vaccine. 92% efficacy, however it will probably be the last thing you ever do.
 
It was actually 1440 out of 11000 in phase 3 trials. I don’t have the numbers for phase 1 and 2.

Overall more data is needed on the over 55’s and that’s why trials are continuing focused on the over 55’s. The results are expected within the next 10 days.

Also note that due to the severe allergic reactions seen with the Pfizer vaccine every person who gets the dose now has to be monitored for 15 minutes following the vaccine.

this has prompted a number of Gp surgery’s to remove themselves from the program as they don’t have the staff to support this. This will only serve to delay the rollout of this particular vaccine.
No such problems seen with the Oxford vaccine.

I think all of us have to bear in mind that development time of all the vaccines was compressed from 3 years to 9 months. That in itself is an unbelievable achievement.

If you’re still not happy to receive the Oxford Vaccine, you could always opt for the Sputnik V vaccine. 92% efficacy, however it will probably be the last thing you ever do.

I'd expect the Sputnik one to....



1608584803522.webp


... send you into orbit.
 
Surely the virus will mutate slightly everywhere anyway, it probably has around other countries but they don't grass themselves up lol
 
Never knew you moonlighted as a medical trial designer Dave, we truly are blessed.
I dont have to be.

It's simple enough to understand that if you want to make sure a trial for a vaccine that's going to overwhelmingly be targeted at stopping death and illness in older age groups, then there needs to be a greater proportion than 1:20 of the participants to be from those age groups.
 
Status
Not open for further replies.

Welcome

Join the Everton conversation today.
Fewer ads, full access, completely free.

🛒 Visit Shop

Support Grand Old Team by checking out our latest Everton gear!
Back
Top